AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
1-Year Est. Return 6.63%
This Quarter Est. Return
1 Year Est. Return
+6.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.09B
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
16
New
Increased
Reduced
Closed

Top Buys

1
+$437M
2
+$138M
3
+$106M
4
REPL icon
Replimune Group
REPL
+$87M
5
IMA
ImageneBio Inc
IMA
+$62.9M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$437M 40.09%
+6,875,698
2
$138M 12.69%
+8,201,638
3
$106M 9.76%
+8,934,902
4
$87M 7.99%
+3,209,627
5
$62.9M 5.78%
+418,182
6
$58.6M 5.38%
+827,888
7
$47.2M 4.34%
+2,232,251
8
$44.1M 4.06%
+2,759,344
9
$36.6M 3.36%
+88,682
10
$17.4M 1.6%
+376,739
11
$16.5M 1.52%
+1,031,160
12
$15.4M 1.41%
+217,284
13
$15.3M 1.4%
+175,146
14
$3.01M 0.28%
+599,524
15
$1.91M 0.18%
+222,976
16
$1.78M 0.16%
+90,072